Pepose Jay
SEC CIK 1866191 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | Dir | 180.5K | $90.1K | — | 10 | 2021-09-13 | 2024-06-11 |
Most active insiders at IRD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | — | $15.99M |
| 2 | Gallagher Cam | Dir | $323.9K | — |
| 3 | Magrath George | CEO, Dir | — | $204.9K |
| 4 | Gagnon Robert E. | CFO | — | $190.8K |
| 5 | YERXA BENJAMIN R | Pres, Dir | — | $61.2K |
| 6 | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | — | $58.2K |
| 7 | SCHACHLE JOSEPH K | COO | — | $57.7K |
| 8 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | — | $23.3K |
| 9 | Bennett Jean | Dir | — | — |
| 10 | Ainsworth Sean | Dir | — | — |
Pepose Jay made no open-market trades at IRD in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-13 | 2024-06-11 | IRD | Opus Genetics, Inc. | Pepose Jay | Dir | A - Grant | $0.00 | +41.1K | 180.5K | +30% | $0 |
| D | 2024-04-15 | 2024-04-11 | IRD | Opus Genetics, Inc. | Pepose Jay | Dir | A - Grant | $0.00 | +32.0K | 139.3K | +30% | $0 |
| 2024-01-03 | 2024-01-01 | IRD | Opus Genetics, Inc. | Pepose Jay | Dir | A - Grant | — | +15.0K | 107.3K | +16% | — | |
| 2023-11-13 | 2023-11-01 | IRD | Opus Genetics, Inc. | Pepose Jay | Dir | A - Grant | $0.00 | +35.0K | 92.4K | +61% | $0 | |
| D | 2023-06-08 | 2023-06-06 | IRD | Opus Genetics, Inc. | Pepose Jay | Dir | A - Grant | $0.00 | +11.0K | 57.4K | +24% | $0 |
| 2023-04-21 | 2023-04-19 | IRD | Opus Genetics, Inc. | Pepose Jay | Dir | A - Grant | — | +468 | 46.4K | +1% | — | |
| D | 2023-01-12 | 2023-01-11 | IRD | Opus Genetics, Inc. | Pepose Jay | Dir | A - Grant | — | +13.0K | 45.9K | +40% | — |
| 2022-07-06 | 2022-07-01 | IRD | Opus Genetics, Inc. | Pepose Jay | Dir | A - Grant | — | +9,900 | 32.9K | +43% | — | |
| 2021-12-14 | 2021-12-13 | IRD | Opus Genetics, Inc. | Pepose Jay | Dir | P - Purchase | $3.65 | +8,250 | 23.0K | +56% | +$30.1K | |
| 2021-09-15 | 2021-09-13 | IRD | Opus Genetics, Inc. | Pepose Jay | Dir | P - Purchase | $4.75 | +12.6K | 14.7K | +598% | +$60.0K |
Purchase Sale Sale after option exercise All abbreviations